MKSAP 19 "Quiz Me!" Question

Test your medical knowledge each month with questions from The Medical Knowledge Self-Assessment Program® (MKSAP).

MKSAP 19MKSAP has been trusted by internists since 1967 as the best resource for updating knowledge. MKSAP 19, available in Complete, Digital, and Print packages, consists of 11 comprehensive text chapters with related multiple-choice questions. You'll find 1,200 completely new questions to help you identify learning gaps, stay current, and gain the knowledge you need to provide the best possible patient care. MKSAP 19's original and high-quality questions evolve out of case studies and patient scenarios based on the latest evidence.

For more information on MKSAP 19, or to order your copy, visit

MKSAP 19 Q & A

A 72-year-old man was diagnosed 9 years ago with prostate cancer. After radiation treatment, his prostate-specific antigen (PSA) level dropped to a nadir of 1.5 ng/mL (1.5 µg/L); it had remained stable until it rose to 2 ng/mL (2 µg/L) 1 year ago and is currently 3.2 ng/mL (3.2 µg/L). He has no symptoms. Medical history is unremarkable, and he takes no medications.

Vital signs and all other physical examination findings are normal. Results of all other laboratory studies are within normal limits.

Biopsy of the prostate is negative. CT of the chest, abdomen, and pelvis and bone scan are negative for metastatic disease.

Which of the following is the most appropriate management?

A: Androgen deprivation therapy
B: Chemotherapy
C: Cryotherapy
D: Monitor PSA level without treatment

Answer and Critique

Back to the March 2023 issue of ACP IMpact